BamSEC and AlphaSense Join Forces
Learn More

Rebus Holdings Inc

Formerly OTC: RBSH
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.01
from 8-K 22 pages Senior Convertible Debenture Due June 18, 2022
12/34/56
EX-10.01
from 8-K 24 pages Senior Convertible Debenture Due January 12, 2022
12/34/56
EX-10.01
from 8-K 3 pages Conversion Price Adjustment Agreement
12/34/56
EX-10.01
from 8-K 20 pages Senior Convertible Debenture Due October 23, 2021
12/34/56
EX-10.01
from 8-K 3 pages Inspyr Therapeutics, Inc. (“Inspyr”) Is Providing This Letter Agreement (“Letter Agreement”) to Ridgeway Therapeutics, Inc. (“Ridgeway”) in Connection With the License Agreement Between Inspyr and Ridgeway Effective as of August 3, 2018 (The “Agreement”). Capitalized Terms Not Otherwise Defined in This Letter Agreement Shall Have the Meaning Ascribed Such Terms in the Agreement. Inspyr and Ridgeway Agree in Consideration of the Mutual Covenants Expressed in This Letter Agreement That With Effect From the Execution of This Letter Agreement
12/34/56
EX-10.25
from 10-K 3 pages Inspyr Therapeutics, Inc. 31200 via Colinas #200 Westlake Village, Ca 91362 Re: Inspyr Therapeutics, Inc. - Subscription for Shares of Series E Preferred Stock
12/34/56
EX-10.01
from 8-K 21 pages Senior Convertible Debenture Due September July 16, 2020
12/34/56
EX-10.23
from 10-K 3 pages Inspyr Therapeutics, Inc. 31200 via Colinas #200 Westlake Village, Ca 91362 Re: Inspyr Therapeutics, Inc. - Subscription for Shares of Series D Preferred Stock
12/34/56
EX-10.02
from 8-K 24 pages Senior Convertible Debenture Due July __, 2019
12/34/56
EX-10.01
from 8-K 45 pages Securities Purchase Agreement
12/34/56
EX-10.03
from 8-K 29 pages Registration Rights Agreement
12/34/56
EX-10.02
from 8-K 25 pages Senior Convertible Debenture Due September 12, 2018
12/34/56
EX-10.02
from 8-K 24 pages Senior Convertible Debenture Due September 12, 2018
12/34/56
EX-10.01
from 8-K 45 pages Securities Purchase Agreement
12/34/56
EX-10.01
from 8-K 14 pages Exchange Agreement
12/34/56
EX-10.2
from 8-K 9 pages Share Escrow Agreement
12/34/56
EX-10.1
from 8-K 54 pages Share Exchange Agreement
12/34/56
EX-10.02
from 8-K 19 pages Series ___ Common Stock Purchase Warrant Inspyr Therapeutics, Inc. Warrant Shares: Initial Exercise Date: March [*], 2017
12/34/56
EX-10.01
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.01
from 8-K 8 pages Separation Agreement
12/34/56